杆菌感染与性结肠炎活动有关吗?
Ayoung Lee1, Jung Wan Choe1, Sung Woo Jung1
1Division of Gastroenterology, Department of Internal Medicine, Korea University College of Medicine, Ansan, Korea.
在大约25%的性结肠炎患者中发现了Helicobacter pylori感染. 这项研究发现,H. pylori感染与性结肠炎症状或疾病活动的严重程度之间没有联系.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 炎症性肠道疾病研究研究
背景情况:
- 流行病学研究表明,Helicobacter pylori感染和性结肠炎 (UC) 之间存在反向关系.
- 了解H. pylori在UC严重性中的潜在保护作用对于患者管理至关重要.
研究的目的:
- 研究H. pylori感染与新诊断的性结肠炎的严重程度之间的关联.
- 为了确定H. pylori感染是否影响UC患者内镜检测结果,临床症状或治疗需求.
主要方法:
- 一项对316名新诊断UC的患者进行的回顾性单中心研究.
- 用上部内镜评估了H. pylori的状态.
- 使用内镜检查结果,临床症状,治疗方案和梅奥分数来评估UC严重程度.
主要成果:
- 在UC队列中,H. pylori感染的患病率为23.4%.
- 在H. pylori阳性和阴性组之间,没有观察到疾病程度,内镜严重程度或UC症状严重程度 (便频率,直肠出血) 的显著差异.
- 类固醇用于诱导疗法和梅奥得分在两组之间没有显著差异.
结论:
- 在显著比例的UC患者中检测到H. pylori感染,但与疾病严重程度无关.
- 通过内镜活动,症状,类固醇使用或梅奥得分来评估UC严重程度,独立于H. pylori感染状态.
更多相关视频
09:05High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability
Published on: November 21, 2014
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
相关概念视频
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
